LPL Financial
NMTR

LPL Financial’s 9 Meters Biopharma NMTR Stock Holding History

LPL Financial’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,736
Closed -$12K – 4605
2022
Q3 		$12K Buy
2,736
+500
+22% +$2.48K ﹤0.01% 4365
2022
Q2 		$12K Hold
2,236
– – ﹤0.01% 4376
2022
Q1 		$27K Sell
2,236
-50
-2% -$683 ﹤0.01% 4105
2021
Q4 		$45K Hold
2,286
– – ﹤0.01% 4244
2021
Q3 		$59K Buy
2,286
+50
+2% +$1.18K ﹤0.01% 4214
2021
Q2 		$49K Buy
2,236
+50
+2% +$1.23K ﹤0.01% 4145
2021
Q1 		$51K Sell
2,186
-55
-2% -$1.69K ﹤0.01% 3994
2020
Q4 		$39K Buy
+2,241
New +$37.4K ﹤0.01% 3746

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

LPL Financial's NMTR Position: Q4 2022 in Review

LPL Financial sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 2,736 shares — an estimated $12K sold.

LPL Financial first reported a position in NMTR in Q4 2020 and held it in 8 quarters. The position peaked at $59K in Q3 2021. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • LPL Financial reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
  • LPL Financial sold 2,736 9 Meters Biopharma shares in Q4 2022, an estimated $12K.
  • LPL Financial first reported a position in 9 Meters Biopharma in Q4 2020 and held it in 8 quarters.
  • LPL Financial's 9 Meters Biopharma position peaked at $59K in Q3 2021.
  • 42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on LPL Financial's 13F filing for Q4 2022, filed 7 Feb 2023.